Drug-induced lung disease adverse effect with Ledipasvir Acetonate/Sofosbuvir

机译：乙哌替丁韦酯/索非布韦的药物引起的肺部不良反应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Results of blood tests

机译：验血结果

著录项

期刊名称 Journal of Pharmaceutical Health Care and Sciences
作者
Sachiko Omotani; Toshihiko Ishizaka; Miki Inoue; Koji Nishida; Yukako Yasui; Yasutoshi Hatsuda; Junji Mukai; Michiaki Myotoku;
展开▼
作者单位

展开▼
年(卷),期 2020(6),-1
年度 2020
页码 -1
总页数 5
原文格式 PDF
正文语种
中图分类药学;
关键词
Chronic hepatitis C; Direct acting antivirals (DAAs); Interstitial lung disease; Drug-induced lung disease;

机译：慢性丙型肝炎;直接作用抗病毒药（DAA）;间质性肺病;药物引起的肺病;
入库时间 2022-08-21 11:42:09

相似文献

外文文献
中文文献
专利

1. Drug-induced lung disease adverse effect with Ledipasvir Acetonate/Sofosbuvir [J] . Sachiko Omotani, Toshihiko Ishizaka, Miki Inoue, Journal of Pharmaceutical Health Care and Sciences . 2020,第1期

机译：药物诱导的肺病与乙酸乙酸/索夫斯布韦尔的肺病不利影响
2. Efficacy and Adverse Event Profile of an Eight Week Ledipasvir-Sofosbuvir Based Hepatitis C Virus (HCV) Treatment Regimen in Human Immune Deficiency Virus (HIV) Patients in a Community Based Setting [J] . Yanny Beshoy, Sahota Amandeep The American Journal of Gastroenterology . 2016,第Suppla1期

机译：基于社区的环境中基于人类免疫缺陷病毒（HIV）患者的八周以Ledipasvir-Sofosbuvir为基础的丙型肝炎病毒（HCV）治疗方案的疗效和不良事件概况
3. Joint Statement of the German Society for Gastroenterology, Digestive- and Metabolic Diseases (DGVS) and the German Society of Internal Medicine (DGIM) on the Ledipasvir/Sofosbuvir-Benefit Assessment in accordance with 35a SGB V of the G-BA [J] . Berg Thomas, Zeuzem Stefan, Manns Michael P. Zeitschrift fur Gastroenterologie . 2015,第5期

机译：德国胃肠病，消化系统和代谢疾病学会（DGVS）和德国内科学学会（DGIM）关于Ledipasvir / Sofosbuvir-Benefit评估的联合声明，符合G-BA的35a SGB V
4. Computer-Aided Assessment of Drug-Induced Lung Disease Plausibility [C] . Brigitte Seroussi, Jacques Bouaud, Hugette Liote, Conference on Artificial Intelligence in Medicine(AIME 2007); 20070707-11; Amsterdam(NL) . 2007

机译：药物诱导的肺部疾病真实性的计算机辅助评估
5. Involvement of Th17 Pathway in Adverse Drug Reactions: Mechanistic Investigation of Drug-Induced Autoimmunity and Drug-induced Liver Injury. [D] . Zhu, Ervin Xu. 2012

机译：Th17途径参与药物不良反应：药物诱发的自身免疫和药物诱发的肝损伤的机制研究。
6. Effectiveness and Safety of Sofosbuvir/Ledipasvir and Paritaprevir/ritonavir/Ombitasvir + Dasabuvir in Patients with Chronic Kidney Diseases: Results from ERCHIVES [O] . Adeel Butt, Yanjie Ren, Amy Puenpatom, 2017

机译：Sofosbuvir / Ledipasvir和Paritaprevir / ritonavir / Ombitasvir + Dasabuvir在慢性肾脏疾病患者中的有效性和安全性：ERCHIVES的结果
7. Successful Treatment of Hepatitis C Virus by Ledipasvir/Sofosbuvir in a Cirrhotic Patient with Sickle Cell Disease and Thalassemia Minor [O] . Hassan Al Moussawi, Abhishek D. Polavarapu, Divya Asti, 2018

机译：用镰状细胞疾病和脑血症患者肝硬化患者乙型肝炎病毒的成功治疗

Drug-induced lung disease adverse effect with Ledipasvir Acetonate/Sofosbuvir

摘要

著录项

相似文献

相关主题

期刊订阅